Xinyun Bioscience Secures Tens of Millions of Yuan in Angel+ Round Financing to Advance Clinical Translation of Intravascular Ultrasound for Cerebrovascular Use

20 hour ago / Read about 0 minute

Author：小编

Cerebrovascular intervention company Xinyun Life Science and Technology (Suzhou) Co., Ltd. recently announced that it has secured tens of millions of yuan in Angel+ round financing from Delian Capital, Zhongguancun Capital, and Sanbo Brain Hospital. This marks the company's second round of financing within a month, following its Angel round financing at the end of August. The investors include market-oriented venture capital firms, early-stage funds with state-owned backgrounds, and industry players specializing in neurology. The proceeds from this round of financing will be used to advance the registration and clinical trials of Neuro-IVUS, conduct type testing, and develop AI-assisted diagnostic software.

Previous page：Tencent WorkBuddy Teams Up with 'Scientific Litera...

Next page：NVIDIA Launches AI Agent Security Platform to Isol...

Return to List

Hot Reading

2 day ago

I created an interactive digital avatar of myself — and you can talk to it

2 day ago

Google tests buying from Walmart-owned Flipkart through Gemini and AI Mode in India

2 day ago

Insurers claim AI is already increasing healthcare costs

1 day ago

TechCrunch Mobility: AV companies pick their lanes